The Veterinary Oncology Market is expected to grow from an estimated USD 12.51 billion in 2024 to USD 29.02 billion in 2033, at a CAGR of 9.8%. The market for veterinary oncology isn developing quickly as more people become aware that cancer is a serious pet health concern. Cancer is a leading cause of pet death, with about 1 in 4 dogs and 1 in 5 cats receiving a diagnosis at some point in their lives, according to the American Veterinary Medical Association (AVMA).
The Veterinary Oncology Market report offers a comprehensive overview of the market along with details about market size, market share, revenue growth, and top companies. The report covers all crucial and essential information related to global Veterinary Oncology market to help readers, investors, clients to gain a thorough understanding of the market and invest accordingly. Various advanced statistical tools such as SWOT analysis or Porter’s Five Forces are used in the report.
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Veterinary Oncology market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
PetCure Oncology, Zoetis, Karyopharm Therapeutics, Inc., Varian Medical Systems, Accuray Incorporated, Boehringer Ingelheim GmbH, Elanco, One Health, Regeneus Ltd.
Emergen Research has segmented the global Veterinary Oncology market on the basis of type, application, end-use, and region:
Segments Covered in this report are:
Animal Type Outlook (Revenue, USD Million; 2020-2033)
Canine
Feline
Equine
Therapy Outlook (Revenue, USD Million; 2020-2033)
Radiotherapy
Surgery
Chemotherapy
Immunotherapy
Other Therapies
Cancer Type Outlook (Revenue, USD Million; 2020-2033)
Skin Cancers
Lymphomas
Sarcomas
Others
The various regions analyzed in the report include:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Veterinary Oncology Market size and share for the projected period of 2022-2030
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Veterinary Oncology Market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.